Why the study?
Increasing life expectancy has expanded the elderly population, in whom rising rates of chronic disease and cardiovascular disease make clinical management an urgent challenge.
This review emphasizes that treating elderly patients with cardiovascular disease should focus on functional status and quality of life rather than strict numerical targets, taking into account frailty and polypharmacy risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ткачева et al. (2019) conducted a review in Cardiovascular diseases (Hypertension, Heart Failure, Atherosclerosis). Cardiovascular pharmacotherapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: